Because these data indicate that GART is highly expressed in ERα-positive IDCs, which are poorly differentiated and metastatic, and that this metabolic protein could play a role in the development of Tam resistance, GART could be considered also a target in BC cell lines resistant to ET. The gene discussed is ESR1; the disease is breast cancer.